COMPARISON OF QUALITY-OF-LIFE DOMAINS USING WHOQOL-BREF IN LEPROSY PATIENTS: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.37268/mjphm/vol.25/no.2/art.2945Keywords:
Hansen's disease, QoL, Neglected tropical disease, Similarities and Differences, Disease impactAbstract
Leprosy is a disease caused by Mycobacterium leprae, affecting the skin, peripheral nerves, eyes, mucous membranes, and other systems. Due to physical disfigurement, disabilities, pain, discomfort, stigma, prejudice, and discrimination, the patients are vulnerable to experiencing a low Quality of Life (QoL). This systematic review aimed to compare the QoL among leprosy patients across geographical and sociodemographic contexts using the World Health Organisation Quality of Life Brief Version (WHOQOL-BREF) questionnaire. It also aims to determine which domains in the WHOQOL-BREF were the most severely affected by leprosy. The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 Checklist, and all criteria related to a systematic review were reported. A structured literature search used three databases: PubMed, Science Direct, and Scopus. The risk bias assessment method used the Mixed Methods Appraisal Tool (MMAT). All studies met the quality criteria between 80 and 100%. Six papers were included from 844 articles identified. All studies were conducted in upper-middle-income countries such as Brazil, Indonesia, and China. The four domains assessed in the WHOQOL-BREF were physical, psychological, social relationships, and environmental. The most severely affected domain in the WHOQOL-BREF was the environmental domain. Three out of the six studies had the lowest score in the environmental domain, with scores ranging from 50.00 to 56.00. The components affected in the environmental domain were related to the home environment, basic amenities, living conditions, financial stability, information availability, and accessibility to social and healthcare services. Notably, targeted interventional programmes should be developed, focusing on the most affected domain in the WHOQOL-BREF to improve the QoL of leprosy patients.
References
World Health Organization. Leprosy [Internet]. 2023 [cited 2024 Sep 18]. Available from: https://www.who.int/news-room/fact-sheets/detail/leprosy
World Health Organization- The Global Health Observatory. Leprosy (Hansen Disease) [Internet]. 2024 [cited 2024 Sep 18]. Available from: https://www.who.int/data/gho/data/themes/topics/leprosy-hansens-disease
Abdul Rahman, N., Rajaratnam, V., Burchell, G. L., et al. Experiences of living with leprosy: A systematic review and qualitative evidence synthesis. PLoS Negl Trop Dis 2022; 16(10), e0010761. https://doi.org/10.1371/journal.pntd.0010761
World Health Organization. Weekly epidemiological record [Internet]. Vol. 98. 2023 [cited 2024 Sep 18]. p. 409–30. Available from: https://reliefweb.int/report/world/weekly-epidemiological-record-wer-8-september-2023-vol-98-no-37-pp-409-430-enfr
World Health Organization. WHOQOL: Measuring Quality of Life [Internet]. 2024 [cited 2024 Sep 18]. Available from: https://www.who.int/tools/whoqol
Govindasamy K, Jacob I, Solomon RM, et al. Burden of depression and anxiety among leprosy affected and associated factors-a cross sectional study from India. PLoS Negl Trop Dis 2021;15(1):1–12. e0009030. doi.org/10.1371/journal.pntd.0009030
Menaldi SL, Harini M, Nelfidayani N, et al. Functional activity limitation of leprosy cases in an endemic area in Indonesia and recommendations for integrated participation program in society. PLoS Negl Trop Dis 2022 Aug 1;16(8). e0010646. https://doi.org/10.1371/journal.pntd.0010646
Harper, A., Power, M., WHOQOL Group, X. Development of the World Health Organization WHOQOLBref quality of life assessment. Psychol Med 1998; 28(3): 551-8. https://doi.org/10.1017/s0033291798006667
Sousa PP de, Sousa ALM de, Turchi MD. Reviewing the therapeutic management of leprosy in primary care: demand case series referred to a University Hospital in the Midwest region of Brazil. An Bras Dermatol 2021 May 1; 96(3):301–8. https://doi.org/10.1016/j.abd.2020.09.005
Richardus JH, Tiwari A, Barth-Jaeggi T, et al. Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme. Lancet Glob Health 2021 Jan 1; 9(1):e81–90. https://doi.org/10.1016/S2214-109X(20)30396-X
Marijke Braet S, Jouet A, Aubry A, et al. Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study. Lancet Microbe 2022 Sep 1; 3(9):e693–700. https://doi.org/10.1016/ S2666-5247(22)00117-3
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 2021 Dec 1; 10(1):89. https://doi.org/10.1186/s13643-021-01626-4
Cochrane Library. What is PICO? [Internet]. 2024 [cited 2024 Sep 19]. Available from: https://www.cochranelibrary.com/about-pico
Division of Mental Health (World Health Organization). WHOQOL-BREF: introduction, administration, scoring and generic version of the assessment : field trial version, December 1996 [Internet]. Geneva; 1996 [cited 2024 Sep 19]. https://iris.who.int/handle/10665/63529
Pluye, P., Gagnon, M. P., Griffiths, F., et al. A scoring system for appraising mixed methods research, and concomitantly appraising qualitative, quantitative and mixed methods primary studies in Mixed Studies Reviews. Int J Nurs Stud 2009; 46(4):529-46. https://doi.org/10.1016/j.ijnurstu.2009.01.009
Pace R, Pluye P, Bartlett G, et al. Testing the reliability and efficiency of the pilot Mixed Methods Appraisal Tool (MMAT) for systematic mixed studies review. Int J Nurs Stud 2012 Jan; 49(1):47–53. https://doi.org/10.1016/j.ijnurstu.2011.07.002
Hong QN, Pluye P, Fàbregues S, et al. Mixed Methods Appraisal Tool (MMAT) Version 2018 User Guide [Internet]. 2018 [cited 2024 Sep 19]. Available from: http://mixedmethodsappraisaltoolpublic.pbworks.com/w/file/fetch/127916259/MMAT_2018_criteria-manual_2018-08-01_ENG.pdf
Lusli M, Peters R, van Brakel W, et al. The Impact of a Rights-Based Counselling Intervention to Reduce Stigma in People Affected by Leprosy in Indonesia. PLoS Negl Trop Dis 2016 Dec 13; 10(12). e0005088. https://doi.org/10.1371/journal.pntd.0005088
Pinto GF, Nicácio RAR, Oliveira FRA de, et al. Factors associated to quality of life in patients with leprosy. Einstein (Sao Paulo, Brazil) 2021; 19:1-7. eAO5936. https://doi.org/10.31744/einstein_journal/2021AO5936
Santos VS, Oliveira LS, Castro FDN, et al. Functional activity limitation and quality of life of leprosy cases in an endemic area in Northeastern Brazil. PLoS Negl Trop Dis 2015; 9(7). e0003900. https://doi.org/10.1371/journal.pntd.0003900
Santos VS, Santana JCV, Castro FDN, et al. Pain and quality of life in leprosy patients in an endemic area of Northeast Brazil: A cross-sectional study. Infect Dis Poverty 2016 Mar 7; 5(1). https://doi.org/10.1186/s40249-016-0113-1
Umniyati H, Zahroh H, Yuliwulandari R. Determinant Factors that Affect the Quality of Life of People with Leprosy in Sumenep, Indonesia. Malaysian journal of public health medicine 2022; 22(1):146–53. https://doi.org/10.37268/mjphm/vol.22/no.1/art.1529
Xu L, Jin G, Li X, et al. Self-Care Ability and Life Quality of Cured Leprosy Patients: The Mediating Effects of Social Support. Healthcare (Switzerland) 2023 Dec 1; 11(23). https://doi.org/10.3390/healthcare11233059
Lambert SM, Nigusse S, Alembo D, et al. Validating an Amharic version of the 36-Item Short Form Health Survey (SF-36) in individuals with leprosy in Ethiopia. Lepr Rev 2023; 94(1):53–69. https://doi.org/10.47276/lr.94.1.53
Tare D, Viswanath V, Pai KS, at al. A Quality of Life Study in Patients with Leprosy Using DLQI and WHOQOL-BREF Questionnaires. Indian J Dermatol 2021; 66(5). https://doi.org/10.4103/ijd.ijd_902_20
Tsutsumi A, Izutsu T, Md Islam A, et al. The quality of life, mental health, and perceived stigma of leprosy patients in Bangladesh. Soc Sci Med 2007 Jun; 64(12):2443–53. https://doi.org/10.1016/j.socscimed.2007.02.014
Division of Mental Health and Prevention of Substance Abuse (World Health Organization). WHOQOL User Manual [Internet]. Geneva; 1998 [cited 2024 Sep 21]. https://iris.who.int/bitstream/handle/10665/77932/WHO_HIS_HSI_Rev.2012.03_eng.pdf?sequence=1
Gan TS, Voo SY@ M. Quality of life of leprosy patients in Sabah. Med J Malaysia 2021 Jan; 76(1):56–60. https://www.e-mjm.org/2021/v76n1/leprosy-patients-life-quality.pdf
Lei HW, Lay LLY, Mei CHC, et al. Anteceding factors predicting absenteeism and presenteeism in urban area in Malaysia. BMC Public Health 2019 Jun 13; 19(Suppl 4). https://doi.org/10.1186/s12889-019-6860-8
Mankar MJ, Joshi SM, Velankar DH, et al. A comparative study of the quality of life, knowledge, attitude and belief about leprosy disease among leprosy patients and community members in Shantivan Leprosy Rehabilitation centre, Nere, Maharashtra, India. J Glob Infect Dis 2011 Oct; 3(4):378–82. https://doi.org/10.4103/0974-777X.91063
Boccolini CS, De Souza Junior PRB. Inequities in Healthcare utilization: Results of the Brazilian National Health Survey, 2013. Int J Equity Health 2016 Nov 17; 15(1). https://doi.org/10.1186/s12939-016-0444-3
